The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy.
Radioimmunotherapy with (131)I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma.
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.
Proliferative glomerulopathy with Unusual Subendothelial Deposits of Striated Structure in Multiple Myeloma.
Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy.
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer.
Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Impact of cycokine gene polymorphisms on risk and treatment outcomes of aplastic anemia.
Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.
Clinical dissection of multicentric Castleman disease.
Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
Acute lymphoblastic leukemia in elderly patients: a single institution’s experience.
Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment.
A case of erdheim-chester disease with asymptomatic renal involvement.
Clinical characteristics and outcomes of primary bone lymphoma in Korea.
RANTES Polymorphisms and the Risk of Graft-versus-Host Disease in Human Leukocyte Antigen-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation.
Repeated Radioimmunotherapy with 131I-Rituximab for Patients with Low-Grade and Aggressive Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Chronic Lymphocytic Leukemia-Era of Targeted Therapy.
Radioimmunotherapy with 131I-rituximab in a patient with diffuse large B-cell lymphoma relapsed after treatment with 90Y-ibritumomab tiuxetan.
EGFR mutation and brain metastasis in pulmonary adenocarcinomas.
Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligibile for autologous stem cell transplantation.
Family caregivers’ awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer.
The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor. ? A retrospective cohort study ?
Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinomas.
Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score.
Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era.
Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.
Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT
Risk stratification model in elderly patients with multiple myeloma: clinical role of magnetic resonance imaging combined with international staging system and cytogenetic abnormalities.
The utility of the serum heavy/light chain assay as a complementary tool in the monitoring of patients with plasma cell myeloma: a report of three cases.
Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial.
A phase II trial of modified FOLFOX6 aqs first-line therpay for adenocarcinoma of an unknown primary site
Visceral adipose tissue is prognostic for survival of diffuse large B-cell lymphoma treated with frontline R-CHOP
. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicenter, retrospective analysis